Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Aarhus University Hospital | OTHER |
| Odense University Hospital | OTHER |
| Zealand University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to investigate the effect of faecal microbiota transplantation (FMT) on eradication of multidrug resistant organisms (MRO) in the intestine. Ultimately, it would be possible to prevent invasive infections with MRO that are difficult to treat and require last-resort antibiotics. The investigators hypothesize that FMT induce intestinal resistance towards colonization with MRO e.g. Vancomycin resistant Enterococcus Faecium (VRE), carbapenemase-producing Enterobacterales (CPE) and extended-spectrum beta-lactamase producing Enterobacterales (ESBL-E).
The study is designed as a randomized, double-blinded and placebo-controlled clinical trial. The participants (n = 80) will be randomized 1:1 to FMT or placebo. FMT or placebo consist of 25-30 capsules which need to be consumed on one day or alternatively consumed over three consecutive days, if one day is unacceptable to the participant. At baseline, eight weeks, and 16 weeks rectal swabs for PCR and culture will be taken. Regarding VRE and CPO, there are specific PCRs followed by confirmatory culture, whereas ESBL-E is detected by culture of rectal swab. Furthermore, participants will be asked to deliver faecal samples as well at baseline and 16 weeks post FMT to examine changes in the intestinal microbiome.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| FMT (faecal microbiota transplantation) | Experimental | 25-30 capsules of faecal material. |
|
| Placebo | Placebo Comparator | 25-30 placebo capsules. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Faecal microbiota transplantation | Other | 25-30 capsules of faecal material |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with MRO clearance | Number of participants with MRO clearance after eight weeks. This will be measured on rectal samples that will undergo PCR/culture for ESBL, VRE and CPO. The results from the test will be positive or negative. | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with MRO clearance | Number of participants with negative PCR for MRO on rectal swab and faecal culture negative for MRO after 16 weeks. This will be measured on rectal samples that will undergo PCR/culture for ESBL, VRE and CPO. The result from the test will be positive or negative | 16 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hvidovre Hospital, Copenhagen University | Hvidovre | Copenhagen | 2650 | Denmark |
Not provided
Randomized.
Not provided
Not provided
Not provided
| Placebo | Other | 25-30 placebo capsules |
|
| Number of participants with adverse events. |
Number of participants with adverse events both severe and non-severe. |
| 8 weeks, 16 weeks and 6 months. |
| Comparison of the frequency of invasive infections | Comparison of the frequency of invasive infections with the same MRO as the intestinal carriage between the FMT and the placebo group. | 6 months |
| Comparison of mortality rates, frequency of hospitalization and isolation between the FMT and the placebo group. | Comparison of mortality rates, frequency of hospitalization and isolation between the FMT and the placebo group. | 6 months |
| Comparison of changes in the diversity of the intestinal microbiome between the FMT group and the placebo group. | Comparison of changes in the diversity of the intestinal microbiome between the FMT group and the placebo group. | 8 weeks and 16 weeks |
| ID | Term |
|---|---|
| D000069467 | Fecal Microbiota Transplantation |
| ID | Term |
|---|---|
| D001691 | Biological Therapy |
| D013812 | Therapeutics |
Not provided
Not provided